Clinical Data Kainova expands DT 7012 trial into Europe PharmaTimesFirst patient dosed as DOMISOL study grows beyond AustraliaClinical DataOncologyRead full story pharminent April 9, 2026 (Last updated: April 9, 2026) PharmaTimes First patient dosed as DOMISOL study grows beyond Australia Clinical DataOncologyRead full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Roche sticks with C4T, adding up to $1B for molecular glue partnershipNext: Innovent’s CDMO gets green light to make biologics at large Chinese plant Related Stories Clinical Data AstraZeneca, Ionis drug fails big heart disease study in major setback pharminent July 9, 2026 Clinical Data Roche’s KRAS drug tops its rivals in lung cancer trial pharminent July 2, 2026 Clinical Data EAN 2026: Real-world data supports safety and efficacy of AbbVie’s Vyalev in Parkinson’s pharminent July 1, 2026
